Variations in Volume: Breast Size in Trans Women in Relation to Timing of Testosterone Suppression - Summary - MDSpire

Variations in Volume: Breast Size in Trans Women in Relation to Timing of Testosterone Suppression

  • By

  • Lidewij S Boogers

  • Sebastiaan A Sardo Infirri

  • Asma Bouchareb

  • Benthe A M Dijkman

  • Danithsia Helder

  • Christel J M de Blok

  • Niels P T J Liberton

  • Martin den Heijer

  • A S Paul van Trotsenburg

  • Koen M A Dreijerink

  • Chantal M Wiepjes

  • Sabine E Hannema

  • August 16, 2024

  • 0 min

Share

Objective:

To investigate the impact of puberty suppression (PS) timing prior to gender-affirming hormone therapy (GAHT) on breast volume and satisfaction in trans women.

Key Findings:
  • Median breast volume was 115 mL, indicating a bra cup size < A.
  • Late PS group had a breast volume 47 mL larger than early PS, but only 4 mL after fat percentage adjustment.
  • Breast volume in the adult group was comparable to both early and late PS groups.
  • 68% of participants were satisfied with their breast size, with varying satisfaction rates across groups.
Interpretation:

Early initiation of PS did not correlate with larger breast volume, suggesting that testosterone exposure during puberty does not adversely affect breast development post-GAHT.

Limitations:
  • Small sample size may limit generalizability.
  • Cross-sectional design does not establish causation.
  • Potential biases in self-reported satisfaction.
Conclusion:

Despite limited breast size, a majority of trans women reported satisfaction with their breast development, indicating the importance of psychological factors in treatment outcomes.

Original Source(s)

Variations in Volume: Breast Size in Trans Women in Relation to Timing of Testosterone Suppression

  • by Lidewij S Boogers, Sebastiaan A Sardo Infirri, Asma Bouchareb, Benthe A M Dijkman, Danithsia Helder, Christel J M de Blok, Niels P T J Liberton, Martin den Heijer, A S Paul van Trotsenburg, Koen M A Dreijerink, Chantal M Wiepjes, Sabine E Hannema

  • August 16, 2024

Related Content

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Editorial: Polycystic ovarian syndrome in adolescence

A Case Report: Treatment, follow-up, and literature review of type A insulin resistance syndrome caused by a De Novo INSR c.3328G>C mutation